Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 2, 2021
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
[ Wed, Jun 02nd 2021
] - WOPRAI
Tue, June 1, 2021
[ Tue, Jun 01st 2021
] - WOPRAI
[ Tue, Jun 01st 2021
] - WOPRAI
[ Tue, Jun 01st 2021
] - WOPRAI
[ Tue, Jun 01st 2021
] - WOPRAI
[ Tue, Jun 01st 2021
] - WOPRAI
[ Tue, Jun 01st 2021
] - WOPRAI
Michelle Gilson Maintained (ASND) at Strong Buy with Increased Target to $196 on, Jun 1st, 2021
Michelle Gilson of Canaccord Genuity, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $190 to $196 on, Jun 1st, 2021.
Michelle has made no other calls on ASND in the last 4 months.
There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Michelle's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Tuesday, March 30th, 2021
These are the ratings of the 2 analyists that currently disagree with Michelle
- David Lebowitz of "Morgan Stanley" Maintained at Buy with Increased Target to $201 on, Friday, May 28th, 2021
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $178 on, Friday, May 28th, 2021
